Acquisition Announced

Galmed Pharmaceuticals acquisition of Colospan

US$4.5m consideration

Announced 8 Jun 2026

Advisers

Colospan

Target

Legal adviser
Matry Meiri Wacht & Co.

Galmed Pharmaceuticals

Acquirer

Financial adviser
Legal adviser
Target
Colospan
Acquirer
Galmed Pharmaceuticals
Target based in
Israel
Buyer based in
Israel
Sector
Medtech

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.